PsyBio Therapeutics Corp. (PSYBF)
| Market Cap | 133.00 -100.0% |
| Revenue (ttm) | n/a |
| Net Income | -1.90M |
| EPS | -0.02 |
| Shares Out | 132.61M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 177,255 |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | -918.22 |
| RSI | 43.74 |
| Earnings Date | n/a |
About PsyBio Therapeutics
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company was incorporated in 2009 and is headquartered in Denver, Colorado. [Read more]
Financial Performance
Financial StatementsNews
PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale
PsyBio continues to develop psycho-targeted, biosynthesized tryptamines and with this authorization becomes the first biotechnology company to obtain government sanctioned, formal, written authorizati...
PsyBio Announces Closing of Third Tranche of Private Placement
Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - April 20, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology ...
PsyBio Announces Closing of Second Tranche of Private Placement
Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - January 13, 2023) - PsyBio Therapeutics Corp.
PsyBio Announces Appointment of Ian Wisenberg to Board of Directors
Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - January 10, 2023) - PsyBio Therapeutics Corp.
PsyBio Announces Closing of First Tranche of Private Placement Led by the Chairman and Chief Executive Officer with Participation from the Entire Board of Directors and Management Team and Provides Corporate Update
Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - January 5, 2023) - PsyBio Therapeutics Corp.
PsyBio Therapeutics to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th
OXFORD, Ohio and COCONUT CREEK, Fla., Oct. 11, 2021 /PRNewswire/ -- PsyBio Therapeutics Corp. (TSXV: PSYB, OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology comp...